TREACE JOHN T. (Chief Executive Officer) purchased 1.3% of their position (85K shares) of TREACE MEDICAL CONCEPTS, INC. on the open market
Open‑market purchase worth $510.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/15/2024ACC: 0000950170-24-097694
DirectorOfficer10% Owner· Chief Executive Officer
Since Apr 2021
+85K
Net shares
Net buyer
$510.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
85K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+85K
Price / share
$6.00
Trade value
$510.31K
% of position
1.3%
8/14/2024
6.39M→6.47M
Total
Net shares
+85K
Net value
$510.31K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/14/2024 | P · Purchase | +85K | $6.00 | $510.31K | 1.3% | 6.39M | 6.47M |
| Total | +85K | $510.31K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned1.47M
Common Stock
IndirectShares owned1.84M
Common Stock
IndirectShares owned408.82K
Common Stock
IndirectShares owned1.60M
Total
5.32M indirect5.32M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.47M | Indirect |
| Common Stock | 1.84M | Indirect |
| Common Stock | 408.82K | Indirect |
| Common Stock | 1.60M | Indirect |
| Total | 5.32M | 5.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported